HBV-话题@MedSci

#HBV#

159篇内容 | 4723人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1836627, encodeId=0ef1183662e27, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应, objectType=article, longId=104502, objectId=60b4104502a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60b4104502a5, replyNumber=0, likeNumber=56, createdTime=2017-10-19, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60b4104502a5, moduleTitle=Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60b4104502a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836621, encodeId=3eba18366213c, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：他汀再添新作用：降低HBV、HCV肝硬化患者失代偿风险, objectType=article, longId=92871, objectId=dd2c928e1a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd2c928e1a9, replyNumber=0, likeNumber=56, createdTime=2017-12-22, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd2c928e1a9, moduleTitle=Hepatology：他汀再添新作用：降低HBV、HCV肝硬化患者失代偿风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd2c928e1a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836617, encodeId=5b83183661e69, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【收藏】医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）, objectType=article, longId=78597, objectId=e0ece8597d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0ece8597d8, replyNumber=0, likeNumber=131, createdTime=2016-10-12, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0ece8597d8, moduleTitle=【收藏】医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0ece8597d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836616, encodeId=2d1b1836616e8, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Hepatol：全球HBV感染情况分析, objectType=article, longId=77171, objectId=cddfe717119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cddfe717119, replyNumber=0, likeNumber=57, createdTime=2017-01-10, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cddfe717119, moduleTitle=J Hepatol：全球HBV感染情况分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cddfe717119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836623, encodeId=fecd18366236d, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Gut：原代肝细胞增殖和预防HBV再感染有效地消耗体内细胞核内cccDNA！, objectType=article, longId=96722, objectId=8df596e229c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df596e229c, replyNumber=0, likeNumber=63, createdTime=2017-05-02, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df596e229c, moduleTitle=Gut：原代肝细胞增殖和预防HBV再感染有效地消耗体内细胞核内cccDNA！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df596e229c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836612, encodeId=e4eb18366129c, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=APT：仅有1.2%的患者能够完全清除HBV病毒, objectType=article, longId=72471, objectId=8c01e2471ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c01e2471ba, replyNumber=0, likeNumber=44, createdTime=2017-06-09, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c01e2471ba, moduleTitle=APT：仅有1.2%的患者能够完全清除HBV病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c01e2471ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836614, encodeId=892c18366141f, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=利用CRISPR/Cas9系统治疗HBV感染取得突破性进展, objectType=article, longId=73883, objectId=802ce3883fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=802ce3883fa, replyNumber=0, likeNumber=49, createdTime=2017-04-05, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=802ce3883fa, moduleTitle=利用CRISPR/Cas9系统治疗HBV感染取得突破性进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=802ce3883fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836618, encodeId=c470183661850, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=医护人员职业暴露后处理流程详解（HBV、HCV，TP、HIV）, objectType=article, longId=78821, objectId=ba55e8821e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba55e8821e3, replyNumber=0, likeNumber=70, createdTime=2017-06-17, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba55e8821e3, moduleTitle=医护人员职业暴露后处理流程详解（HBV、HCV，TP、HIV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba55e8821e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836613, encodeId=092718366136f, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=“神药”OSU-03012不仅抑制多种肿瘤，也能抑制众多细菌和HIV、HAV、HBV、HCV等众多病毒, objectType=article, longId=73286, objectId=212ae328610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=212ae328610, replyNumber=0, likeNumber=68, createdTime=2016-12-20, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=212ae328610, moduleTitle=“神药”OSU-03012不仅抑制多种肿瘤，也能抑制众多细菌和HIV、HAV、HBV、HCV等众多病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=212ae328610)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836611, encodeId=a311183661110, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J immunol：NF-KB参与抗HBV感染天然免疫反应, objectType=article, longId=71007, objectId=7161e10071c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7161e10071c, replyNumber=0, likeNumber=83, createdTime=2016-11-05, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7161e10071c, moduleTitle=J immunol：NF-KB参与抗HBV感染天然免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7161e10071c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836608, encodeId=dff4183660817, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：核苷（酸）类似物治疗可降低HBV相关性HCC的复发率, objectType=article, longId=69264, objectId=6ce26926482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ce26926482, replyNumber=0, likeNumber=61, createdTime=2016-07-23, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ce26926482, moduleTitle=Hepatology：核苷（酸）类似物治疗可降低HBV相关性HCC的复发率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ce26926482)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836615, encodeId=5620183661554, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Am J Gastroenterol：乙肝孕妇HBV DNA和ALT研究, objectType=article, longId=74850, objectId=c506e4850f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c506e4850f9, replyNumber=0, likeNumber=0, createdTime=2017-04-21, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c506e4850f9, moduleTitle=Am J Gastroenterol：乙肝孕妇HBV DNA和ALT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c506e4850f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836610, encodeId=31ee183661060, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=ADA 2016：糖尿病患者HBV疫苗HEPLISAV-B安全性和有效性研究, objectType=article, longId=70539, objectId=a176e053962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a176e053962, replyNumber=0, likeNumber=52, createdTime=2017-05-18, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a176e053962, moduleTitle=ADA 2016：糖尿病患者HBV疫苗HEPLISAV-B安全性和有效性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a176e053962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836609, encodeId=09aa18366097d, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效, objectType=article, longId=70398, objectId=4835e039867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4835e039867, replyNumber=0, likeNumber=50, createdTime=2016-11-13, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4835e039867, moduleTitle=EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4835e039867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836607, encodeId=b082183660e39, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=ILC 2016：NVR 3-778可安全地降低慢性乙型肝炎患者的HBV DNA的水平, objectType=article, longId=66617, objectId=c6ce6661ea9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6ce6661ea9, replyNumber=0, likeNumber=59, createdTime=2017-01-04, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6ce6661ea9, moduleTitle=ILC 2016：NVR 3-778可安全地降低慢性乙型肝炎患者的HBV DNA的水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6ce6661ea9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836606, encodeId=5e3f1836606df, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=PLoS One：对HBV有免疫性可减少糖尿病风险, objectType=article, longId=58478, objectId=50e5584e8c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50e5584e8c3, replyNumber=0, likeNumber=56, createdTime=2016-08-06, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50e5584e8c3, moduleTitle=PLoS One：对HBV有免疫性可减少糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50e5584e8c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836605, encodeId=e454183660577, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Ann Intern Med：男男做爱，除了HIV，HBV感染率也很高, objectType=article, longId=57935, objectId=779a5e93579, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=779a5e93579, replyNumber=0, likeNumber=30, createdTime=2016-04-01, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=779a5e93579, moduleTitle=Ann Intern Med：男男做爱，除了HIV，HBV感染率也很高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=779a5e93579)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836600, encodeId=26bf1836600f1, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=从免疫学角度，论抗HBV治疗新策略, objectType=article, longId=48555, objectId=7c3748555cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c3748555cc, replyNumber=0, likeNumber=62, createdTime=2015-06-12, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c3748555cc, moduleTitle=从免疫学角度，论抗HBV治疗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c3748555cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836602, encodeId=882d183660266, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Gut：HBV患者血清dlDNA比例的增加与肝病的进展有关, objectType=article, longId=52557, objectId=10385255e2d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10385255e2d, replyNumber=0, likeNumber=60, createdTime=2016-03-16, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10385255e2d, moduleTitle=Gut：HBV患者血清dlDNA比例的增加与肝病的进展有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10385255e2d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836598, encodeId=95051836598a0, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Journal of Hepatology：慢性HBV感染的死亡原因分析, objectType=article, longId=47557, objectId=93b14e55789, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93b14e55789, replyNumber=0, likeNumber=95, createdTime=2015-11-15, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93b14e55789, moduleTitle=Journal of Hepatology：慢性HBV感染的死亡原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93b14e55789)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HBV

2020-05-29

klivis (审核中...)

前往app查看评论内容

#HBV#

Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应

2017-10-19

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology：他汀再添新作用：降低HBV、HCV肝硬化患者失代偿风险

2017-12-22

klivis (审核中...)

前往app查看评论内容

#HBV#

【收藏】医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）

2016-10-12

klivis (审核中...)

前往app查看评论内容

#HBV#

J Hepatol：全球HBV感染情况分析

2017-01-10

klivis (审核中...)

前往app查看评论内容

#HBV#

Gut：原代肝细胞增殖和预防HBV再感染有效地消耗体内细胞核内cccDNA！

2017-05-02

klivis (审核中...)

前往app查看评论内容

#HBV#

APT：仅有1.2%的患者能够完全清除HBV病毒

2017-06-09

klivis (审核中...)

前往app查看评论内容

#HBV#

利用CRISPR/Cas9系统治疗HBV感染取得突破性进展

2017-04-05

klivis (审核中...)

前往app查看评论内容

#HBV#

医护人员职业暴露后处理流程详解（HBV、HCV，TP、HIV）

2017-06-17

klivis (审核中...)

前往app查看评论内容

#HBV#

“神药”OSU-03012不仅抑制多种肿瘤，也能抑制众多细菌和HIV、HAV、HBV、HCV等众多病毒

2016-12-20

klivis (审核中...)

前往app查看评论内容

#HBV#

J immunol：NF-KB参与抗HBV感染天然免疫反应

2016-11-05

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology：核苷（酸）类似物治疗可降低HBV相关性HCC的复发率

2016-07-23

klivis (审核中...)

前往app查看评论内容

#HBV#

Am J Gastroenterol：乙肝孕妇HBV DNA和ALT研究

2017-04-21

klivis (审核中...)

前往app查看评论内容

#HBV#

ADA 2016：糖尿病患者HBV疫苗HEPLISAV-B安全性和有效性研究

2017-05-18

klivis (审核中...)

前往app查看评论内容

#HBV#

EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效

2016-11-13

klivis (审核中...)

前往app查看评论内容

#HBV#

ILC 2016：NVR 3-778可安全地降低慢性乙型肝炎患者的HBV DNA的水平

2017-01-04

klivis (审核中...)

前往app查看评论内容

#HBV#

PLoS One：对HBV有免疫性可减少糖尿病风险

2016-08-06

klivis (审核中...)

前往app查看评论内容

#HBV#

Ann Intern Med：男男做爱，除了HIV，HBV感染率也很高

2016-04-01

klivis (审核中...)

前往app查看评论内容

#HBV#

从免疫学角度，论抗HBV治疗新策略

2015-06-12

klivis (审核中...)

前往app查看评论内容

#HBV#

Gut：HBV患者血清dlDNA比例的增加与肝病的进展有关

2016-03-16

klivis (审核中...)

前往app查看评论内容

#HBV#

Journal of Hepatology：慢性HBV感染的死亡原因分析

2015-11-15

科室
- - 订阅+
  - 更多科室
工具
服务